⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Tenax Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
TENX
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
globenewswire.com
TENX
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
globenewswire.com
TENX